Omnicare Clinical Research Licenses LiquentConnect to Create Added Value for Clients

PHILADELPHIA, January 26 - Liquent, Inc. today announced Omnicare Clinical Research has licensed
LiquentConnect(R) - a hosted software as a service (SaaS) solution used to
quickly and easily create, review, amend and submit regulatory dossiers.
Omnicare Clinical Research is a leading Phase I to IV global contract
research organization serving the biopharmaceutical and medical device
industries.

LiquentConnect enables organizations to produce their own eCTD and non
electronic submissions without investing in IT infrastructure. All software
and hardware upgrades are managed and executed by Liquent. LiquentConnect is
fully executable for eCTD, NeeS and CTD publishing.

"As portions of the industry shift toward SaaS, we are pleased to offer
LiquentConnect, a SaaS solution publishing tool," said Rick Riegel, Liquent's
Chief Executive Officer. "Liquent is committed to providing value-add
solutions to our customers. LiquentConnect provides reliable, secure access
to your dossiers from anywhere with an internet connection."

Omnicare Clinical Research selected Liquent and will be utilizing
LiquentConnect as its hosted solution provider due to Liquent's depth of
expertise within the regulatory and life-sciences industry. The benefits of
implementing a fully-managed SaaS solution outweighed the time and resource
investment required for other solutions.

"LiquentConnect provides our organization and our customers with project
submission data that is safe and secure. Liquent provided us with a solution
that is not only flexible, but one that we believe can expand to meet our
needs and offer an efficient and cost-effective tool to address a variety of
situations, from eCTD to NeeS to paper," said Dr. Martine Dehlinger-Kremer,
Vice President of Global Regulatory Affairs for Omnicare Clinical Research.

About Omnicare Clinical Research

Established in 1985, Omnicare Clinical Research is a full-service CRO,
with diverse therapeutic expertise and comprehensive clinical service
offerings, supporting the pharmaceutical industry throughout every aspect of
a clinical project. Furthermore, the Company features specialized expertise
in phase I-III clinical services, clinical supplies packaging, labeling,
storage and distribution services, and functional service provider
relationships from its office locations in over 30 countries worldwide.
Omnicare Clinical Research is a subsidiary of Omnicare, Inc. (NYSE: OCR), a
leading provider of pharmacy services to long-term care facilities and other
chronic care settings comprising approximately 1.4 million beds in 47 states,
the District of Columbia and Canada. www.omnicareCR.com.

About Liquent, Inc.

Liquent regulatory solutions provide software and related regulatory and
clinical services for the life sciences industry. These solutions and
services help ensure clients meet the strict standards of regulatory
authorities across the world helping them achieve quality, accuracy, and data
integrity to deliver regulatory reports and submissions reliably and on time.
For more information please visit, www.liquent.com.

Rick Riegel, CEO of Liquent, Inc., +1-215-328-4302